Biocorp Production Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Eric Dessertenne

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	3.8yrs
Participación del CEO	n/a
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	8.4yrs

Actualizaciones recientes de la dirección

Recent updates

Would Biocorp Production (EPA:ALCOR) Be Better Off With Less Debt?

Dec 08

What Does The Future Hold For Biocorp Production (EPA:ALCOR)? These Analysts Have Been Cutting Their Estimates

Jun 26

Biocorp Production (EPA:ALCOR) Just Reported And Analysts Have Been Cutting Their Estimates

Apr 11

What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

Mar 04

Is Biocorp Production's (EPA:ALCOR) Share Price Gain Of 179% Well Earned?

Jan 10

What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

Nov 18

CEO

Eric Dessertenne

3.8yrs

Permanencia

Mr. Eric Dessertenne has been Chief Executive Officer at Biocorp Production since December 23, 2019 and its Director since September 24, 2021. He had been Chief Operating Officer of Biocorp Production sinc...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Eric Dessertenne	CEO & Director	2.1yrs	sin datos	sin datos
Jean-Yves Berthon	Independent Director	8.4yrs	sin datos	sin datos
Lutz Heinemann	Member of Scientific Advisory Board	no data	sin datos	sin datos
Stephane Legastelois	Independent Director	8.4yrs	sin datos	sin datos
Julien Gardette	Director	8.4yrs	sin datos	sin datos
Jean-Pierre Riveline	Member of Scientific Advisory Board	no data	sin datos	sin datos
Pauline Schaepelynck-Belicar	Member of Scientific Advisory Board	no data	sin datos	sin datos
Novo Nordisk	Chairman of the Board	no data	sin datos	sin datos

8.4yrs

Permanencia media

Junta con experiencia: La junta directiva de ALCOR se considera experimentada (8.4 años de antigüedad promedio).

Biocorp Production Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Less than half of directors are independent

Less than half of directors are independent

Recent updates

First half 2023 earnings released: €0.86 loss per share (vs €0.53 loss in 1H 2022)

Novo Nordisk A/S (CPSE:NOVO B) agreed to acquire a 64.4% stake in Biocorp Production (ENXTPA:ALCOR) for €99.1 million.

Novo Nordisk Enters into Exclusive Negotiations to Acquire A Controlling Stake in Bicorp, to Be Followed by A Tender Offer on All Remaining Shares

Full year 2022 earnings released

Biocorp Production to Report First Half, 2023 Results on Sep 28, 2023

Biocorp Production announced that it has received €2.5 million in funding from Vatel Capital SAS

Would Biocorp Production (EPA:ALCOR) Be Better Off With Less Debt?

Biocorp Production Obtains 510(K) FDA Clearance for Mallya

Less than half of directors are independent

First half 2022 earnings released: EPS: €0 (vs €0.28 loss in 1H 2021)

Consensus EPS estimates increase by 38%

What Does The Future Hold For Biocorp Production (EPA:ALCOR)? These Analysts Have Been Cutting Their Estimates

Consensus forecasts updated

Price target increased to €36.53

Less than half of directors are independent

Full year 2021 earnings: Revenues miss analyst expectations

First half 2021 earnings released

Biocorp Production (EPA:ALCOR) Just Reported And Analysts Have Been Cutting Their Estimates

Full year 2020 earnings released

New 90-day high: €30.60

What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

BIOCORP Announces the Signature of New Partnerships with Health2sync and SocialDiabetes

New 90-day high: €30.40

Is Biocorp Production's (EPA:ALCOR) Share Price Gain Of 179% Well Earned?

Biocorp Production to Report Fiscal Year 2020 Results on Apr 08, 2021

What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

BIOCORP Announces Launch of Mallya

New 90-day high: €33.00

Biocorp Production Announces Partnership with AARDEX Group to Extend Smart Solutions for Precision Medication Adherence

New 90-day high - €28.50

CEO

Permanencia

Miembros de la Junta

Permanencia media